What is Charles River?
Charles River is a prominent entity dedicated to accelerating the development of critical solutions across the drug, chemical, and medical device industries. Its comprehensive product and service portfolio spans the entire lifecycle from basic research and discovery through safety assessment, manufacturing, and commercialization. By offering an expansive, end-to-end suite of capabilities, global capacity, and seasoned scientific and regulatory expertise, Charles River employs an integrated approach designed to maximize speed and instill confidence in bringing market-ready innovations to fruition.
How much funding has Charles River raised?
Charles River has raised a total of $258M across 2 funding rounds:
Stock Offering
$224M
Unspecified
$34M
Stock Issuance/Offering (2000): $224M, investors not publicly disclosed
Unspecified (2011): $34M led by National Institutes of Health
Key Investors in Charles River
National Institutes of Health
The National Institutes of Health (NIH) is a primary agency of the U.S. Department of Health and Human Services, responsible for biomedical and health-related research, providing significant backing for scientific advancement.
What's next for Charles River?
The recent major strategic investment signals a pivotal phase for Charles River, likely aimed at expanding its operational capacity, enhancing its research and development pipeline, or pursuing strategic acquisitions. Given its established track record and the nature of the recent capital, the company is well-positioned for continued growth and innovation in the life sciences sector. Future endeavors will likely focus on leveraging this strategic backing to further solidify its market leadership and address unmet needs in drug and medical device development.
See full Charles River company page
